eBehandling - Health and Work for Patients in Specialist Mental Health Care

NCT06568419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-04-23

No results posted yet for this study

Summary

Mental health problems and disorders affect one in every five amongst the working- age adults in the countries of the Organization for Economic Cooperation and Development. This constitutes a major public health challenge that also has large implications for work participation and productivity.

Major depression and anxiety are the most prevalent of the mental disorders and are therefore named common mental disorders (CMD). CMD have become a major cause of work absenteeism, with 30% of all sick leave in Norway being due to CMDs in 2024.

Early interventions addressing psychological aspects and vocational challenges related to work have shown a positive effect on return to work. Therefore, finding ways to increase availability and reduce barriers to evidence-based treatments seems a viable route to reducing mental health's impact on sick leave and absenteeism.

Research show that improvement in symptoms from ordinary psychotherapy has little impact on sick-leave. The same results have been found for internet-based cognitive therapy (ICBT). One of the challenges in specialised mental health care is that the work focus has been an additive or extended part of the treatment, not integrated in the treatment itself.

Several studies have been conducted on psychological treatments that specifically target return to work for people with CMDs. Systematic reviews have shown that work-focused therapy has a small, but significant effect over treatment as usual on return to work and finds that 20% more workers in the intervention groups had returned to work, compared to control groups.

The availability of traditional therapy is scarce and there is an need for new effective ways of delivery. internet-based cognitive therapy has been shown to be as effective as traditional therapy in many systematic reviews and meta analysis and seems a good approach to reach the goal of increasing availability.

To account for the heterogene group of people on sick leave the investigators have created a transdiagnostic, work-focused internet-based cognitive behaviloural therapy program.

This study aims is to is to investigate the utility and use of this treatment program for patients with common mental health disorders on sick leave or work assessment allowance. This includes the user experience of participation and experienced utility of the treatment program.

Conditions

Interventions

BEHAVIORAL

Transdiagnostic, work-focused Cognitive Behavioural Therapy

Transdiagnostic, work-focused Cognitive Behavioural Therapy focuses on core mechanisms that creates and maintain illness in depression and anxiety. Namely reducing avoidance and/or suppression of unwanted thoughts, avoidance of meaningful activity and increase cognitive flexibility while under psychological stress.

Sponsors & Collaborators

  • Sykehuset Innlandet HF

    collaborator OTHER
  • Sykehuset Ostfold

    collaborator OTHER
  • Sykehuset i Vestfold HF

    collaborator OTHER
  • University Hospital, Aker

    collaborator OTHER
  • Helse Fonna

    collaborator OTHER
  • Helse Bergen Hospital Trust

    collaborator UNKNOWN
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Macquarie University, Australia

    collaborator OTHER
  • Diakonhjemmet Hospital

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Solli Distriktspsykiatriske Senter

    lead OTHER

Principal Investigators

  • Pål William Wallace, PhD · Solli DPS

  • Kristine Sirevåg, MSc · Solli DPS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2027-04-30
Completion
2028-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06568419 on ClinicalTrials.gov